Evidence map›Paper›PMID 31200669›Full record

ArticleBMC surgery2019

Intraoperative tumor lysis syndrome in a giant teratoma: a case report.

Daniel Pindak, Katarina Rejlekova, Miroslav Tomas, Ramadan Aziri, Eva Rovenska, Judita Puskacova, Michal Mego

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Daniel PindakDepartment of Surgical Oncology, National Cancer Institute Bratislava, Bratislava, Slovakia.
Katarina Rejlekova2nd Department of Oncology Faculty of Medicine, Comenius University, Bratislava, Slovakia. k.rejlekova@gmail.com.ORCID http://orcid.org/0000-0002-2142-3411
Miroslav TomasDepartment of Surgical Oncology, National Cancer Institute Bratislava, Bratislava, Slovakia.
Ramadan AziriDepartment of Surgical Oncology, National Cancer Institute Bratislava, Bratislava, Slovakia.
Eva RovenskaDepartment of Surgical Oncology, National Cancer Institute Bratislava, Bratislava, Slovakia.
Judita PuskacovaDepartment of Pediatric Hematology and Oncology, Comenius University Children's Hospital, Bratislava, Slovakia.
Michal Mego2nd Department of Oncology Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Comenius University Bratislava · SKNational Institute of Cardiovascular Diseases · SKSlovak Medical University · SK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTumor lysis syndrome is an unusual metabolic emergency in solid tumors. Perioperative occurrence of this syndrome is extremely rare but may have fatal consequences if not detected and treated on time. CASE REPORT: We report a 19-year patient with testicular germ cell tumor after first line chemotherapy with giant growing teratoma syndrome in retroperitoneum. He underwent radical resection, however, perioperatively, a fatal case of heart failure due to unrecognized intraoperative tumor lysis syndrome developed.

conclusionSurgeons, anesthesiologists and oncologists should be aware of this complication in order to be prepared for such an emergency.

Indexed as

CisplatinHumansLung NeoplasmsLymphatic MetastasisMaleNeoplasms, Germ Cell and EmbryonalOrchiectomyPrognosisRetroperitoneal NeoplasmsRetroperitoneal SpaceTeratomaTesticular NeoplasmsTumor Lysis SyndromeYoung AdultCisplatinGenitourinary neoplasmIntraoperativeNecrosisSurgeryTeratoma

Identifiers

PMID31200669
PMCPMC6570972
OpenAlexW2953234009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.